FDA Inspection 982333 — GlaxoSmithKline Manufacturing S.p.A.
The FDA completed an inspection of GlaxoSmithKline Manufacturing S.p.A. on July 22, 2016 in Torrile. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Torrile (Italy)